---
title: "What will the FDA's decision be on Bepirovirsen by GlaxoSmithKline in 2026?"
canonical_url: https://betcrypto.now/events/what-will-the-fdas-decision-be-on-bepirovirsen-by-glaxosmithkline-in-2026
status: live
trading_closes_at: 2027-01-01T04:59:00+00:00
total_volume_usd: 4160.51
venues: ["Kalshi"]
categories: ["Markets"]
prices_as_of: 2026-10-09T12:28:20+00:00
publisher: BetCrypto
data_api: https://betcrypto.now/api/v1/events/what-will-the-fdas-decision-be-on-bepirovirsen-by-glaxosmithkline-in-2026
---

# What will the FDA's decision be on Bepirovirsen by GlaxoSmithKline in 2026?

Live · $4,161 traded · listed on Kalshi

## About

If the FDA's decision on Bepirovirsen by GlaxoSmithKline in 2026 is a full approval or an accelerated approval, the market resolves to Yes.

This market will resolve to No if the FDA's decision is a denial (CRL issued), a withdrawal by the sponsor, or a conditional approval — or if no decision is issued. 

Bepirovirsen is an experimental antiviral medicine developed by GlaxoSmithKline that is designed to clear the hepatitis B virus from the body rather than just keeping it asleep. It belongs to a modern class of gene-silencing therapies that hunt down and destroy the virus's replication instructions. This is similar to intercepting and shredding a virus’s blueprints before its cell-invading factory has a chance to read them and build new viral copies.

_From Kalshi's listing._

## Main market

| Outcome | Probability | Cheapest | Kalshi |
|---|---|---|---|
| Yes | 93% | 93¢ on Kalshi | 93¢ |
| No | — | 7¢ on Kalshi | 7¢ |

## Open on a venue

- [Kalshi](https://betcrypto.now/go/e/2327?via=md)

---

Probability is the cross-venue consensus (book midpoints, 0–100%). Venue columns are what buying costs there (the ask). Prices move constantly; re-check at the canonical URL or https://betcrypto.now/api/v1/events/what-will-the-fdas-decision-be-on-bepirovirsen-by-glaxosmithkline-in-2026.

BetCrypto is an odds-comparison and information service. It accepts no wagers and gives no betting or financial advice; prediction-market availability depends on where you live.